MafB oncoprotein detected by immunohistochemistry as a highly sensitive and specific marker for the prognostic unfavorable t(14;20) (q32;q12) in multiple myeloma patients

被引：12

作者：

Stralen, Ev ^{[1
,2
]}

Leguit, R. J. ^{[3
]}

Begthel, H. ^{[2
]}

Michaux, L. ^{[4
]}

Buijs, A. ^{[5
]}

Lemmens, H. ^{[4
]}

Scheiff, J. M. ^{[6
]}

Doyen, C. ^{[7
]}

Pierre, P. ^{[8
]}

Forget, F. ^{[9
]}

Clevers, H. C. ^{[2
]}

Bast, B. J. E. G. ^{[1
]}

机构：

[1] Univ Med Ctr, Dept Immunol, Utrecht, Netherlands

[2] Ctr Dev Biol & Stem Cell Res, Hubrecht Lab, Utrecht, Netherlands

[3] Univ Med Ctr Utrecht, Dept Pathol, Utrecht, Netherlands

[4] Univ Leuven, Ctr Human Genet, Louvain, Belgium

[5] Univ Med Ctr Utrecht, Dept Med Genet, Utrecht, Netherlands

[6] UCL St Luc, Dept Biol Clin, Brussels, Belgium

[7] UCL Mt Godinne, Dept Hematol, Brussels, Belgium

[8] Clin St Joseph, Dept Hematol, Arlon, Belgium

[9] CH De LArdenne, Dept Hematol, Libramont, Belgium

来源：

LEUKEMIA | 2009年 / 23卷 / 04期

关键词：

C-MAF; ABERRANT EXPRESSION; TRANSLOCATION; T(4/14);

D O I：

10.1038/leu.2008.284

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：801 / 803

页数：4

共 11 条

[1] The recurrent translocation t(14;20)(q32;q12) in multiple myeloma results in aberrant expression of MAFB:: a molecular and genetic analysis of the chromosomal breakpoint [J].

Boersma-Vreugdenhil, GR ;

Kuipers, J ;

van Stralen, E ;

Peeters, T ;

Michaux, L ;

Hagemeijer, A ;

Pearson, PL ;

Clevers, HC ;

Bast, BJEG .

BRITISH JOURNAL OF HAEMATOLOGY, 2004, 126 (03) :355-363

[2] Translocation of the IgH locus is nearly ubiquitous in multiple myeloma as detected by immuno-FISH [J].

Boersma-Vreugdenhil, GR ;

Peeters, T ;

Bast, BJEG .

BLOOD, 2003, 101 (04) :1653-1653

[3] Immunohistochemistry accurately predicts FGFR3 aberrant expression and t(4;14) in multiple myeloma [J].

Chang, H ;

Stewart, AK ;

Qi, XY ;

Li, ZH ;

Yi, QL ;

Trudel, S .

BLOOD, 2005, 106 (01) :353-355

[4] c-Maf nuclear oncoprotein is frequently expressed in multiple myeloma [J].

Chang, Hong ;

Qi, Q. ;

Xu, W. ;

Patterson, B. .

LEUKEMIA, 2007, 21 (07) :1572-1574

[5] Genetic events in the pathogenesis of multiple myeloma [J].

Chng, W. J. ;

Glebov, O. ;

Bergsagel, R. L. ;

Kuehl, W. M. .

BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2007, 20 (04) :571-596

[6] Overexpression of c-maf is a frequent oncogenic event in multiple myeloma that promotes proliferation and pathological interactions with bone marrow stroma [J].

Hurt, EM ;

Wiestner, A ;

Rosenwald, A ;

Shaffer, AL ;

Campo, E ;

Grogan, T ;

Bergsagel, PL ;

Kuehl, WM ;

Staudt, LM .

CANCER CELL, 2004, 5 (02) :191-199

[7] c-maf oncogene dysregulation in multiple myeloma: Frequency and biological relevance [J].

Rasmussen, T ;

Knudsen, LM ;

Dahl, IMS ;

Johnsen, HE .

LEUKEMIA & LYMPHOMA, 2003, 44 (10) :1761-1766

[8] MafB is an interaction partner and repressor of Ets-1 that inhibits erythroid differentiation [J].

Sieweke, MH ;

Tekotte, H ;

Frampton, J ;

Graf, T .

CELL, 1996, 85 (01) :49-60

[9] The inhibitory anti-FGFR3 antibody, PRO-001, is cytotoxic to t(4;14) multiple myeloma cells [J].

Trudel, Suzanne ;

Stewart, A. Keith ;

Rom, Eran ;

Wei, Ellen ;

Li, Zhi Hua ;

Kotzer, Sarit ;

Chumakov, Irina ;

Singer, Yossi ;

Chang, Hong ;

Liang, Sheng-Ben ;

Yayon, Avner .

BLOOD, 2006, 107 (10) :4039-4046

[10] Wnt signaling controls the phosphorylation status of β-catenin [J].

van Noort, M ;

Meeldijk, J ;

van der Zee, R ;

Destree, O ;

Clevers, H .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (20) :17901-17905

← 1 2 →